Login Register Cart 0
Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Safety Issues of Herb-Warfarin Interactions

Author(s): Subhajit Hazra, Preet Amol Singh* and Neha Bajwa

Volume 25, Issue 1, 2024

Published on: 08 March, 2024

Page: [13 - 27] Pages: 15

DOI: 10.2174/0113892002290846240228061506

Price: $65

Abstract

Warfarin is a popular anticoagulant with high global demand. However, studies have underlined serious safety issues when warfarin is consumed concomitantly with herbs or its formulations. This review aimed to highlight the mechanisms behind herb-warfarin interactions while laying special emphasis on its PKPD interactions and evidence on Herb-Warfarin Interaction (HWI) with regards to three different scenarios, such as when warfarin is consumed with herbs, taken as foods or prescribed as medicine, or when used in special situations. A targeted literature methodology involving different scientific databases was adopted for acquiring information on the subject of HWIs. Results of the present study revealed some of the fatal consequences of HWI, including post-operative bleeding, thrombosis, subarachnoid hemorrhage, and subdural hematomas occurring as a result of interactions between warfarin and herbs or commonly associated food products from Hypericum perforatum, Zingiber officinale, Vaccinium oxycoccos, Citrus paradisi, and Punica granatum. In terms of PK-PD parameters, herbs, such as Coptis chinensis Franch. and Phellodendron amurense Rupr., were found to compete with warfarin for binding with plasma proteins, leading to an increase in free warfarin levels in the bloodstream, resulting in its augmented antithrombic effect. Besides, HWIs were also found to decrease International Normalised Ratio (INR) levels following the consumption of Persea americana or avocado. Therefore, there is an urgent need for an up-to-date interaction database to educate patients and healthcare providers on these interactions, besides promoting the adoption of novel technologies, such as natural language processing, by healthcare professionals to guide them in making informed decisions to avoid HWIs.

« Previous Next »
Graphical Abstract

[1]
Ge, B.; Zhang, Z.; Zuo, Z. Updates on the clinical evidenced herb-warfarin interactions. Evid. Based Complement. Alternat. Med., 2014, 2014, 1-18.
[http://dx.doi.org/10.1155/2014/957362] [PMID: 24790635]
[2]
Ramalingum, N.; Mahomoodally, M.F. The therapeutic potential of medicinal foods. Adv. Pharmacol. Sci., 2014, 2014, 1-18.
[http://dx.doi.org/10.1155/2014/354264] [PMID: 24822061]
[3]
Chen, X.W.B.; Sneed, K.B.; Pan, S.Y.; Cao, C.; Kanwar, J.R.; Chew, H.; Zhou, S.F. Herb-drug interactions and mechanistic and clinical considerations. Curr. Drug Metab., 2012, 13(5), 640-651.
[http://dx.doi.org/10.2174/1389200211209050640] [PMID: 22292789]
[4]
Milić, N.; Milošević, N.; Kon, S.G.; Božić, T.; Abenavoli, L.; Borrelli, F. Warfarin interactions with medicinal herbs. Nat. Prod. Commun., 2014, 9(8), 1934578X1400900.
[http://dx.doi.org/10.1177/1934578X1400900835] [PMID: 25233607]
[5]
Tan, C.S.S.; Lee, S.W.H. Warfarin and food, herbal or dietary supplement interactions: A systematic review. Br. J. Clin. Pharmacol., 2021, 87(2), 352-374.
[http://dx.doi.org/10.1111/bcp.14404] [PMID: 32478963]
[6]
AlMatar, M.; Var, I.; Kayar, B.; Eker, E.; Kafkas, E.; Zarifikhosroshahi, M.; Köksal, F. Evaluation of polyphenolic profile and antibacterial activity of pomegranate juice in combination with rifampin (R) against MDR-TB clinical isolates. Curr. Pharm. Biotechnol., 2019, 20(4), 317-326.
[http://dx.doi.org/10.2174/1389201020666190308130343] [PMID: 30854955]
[7]
Mak, M.; Lam, C.; Pineda, S.J.; Lou, M.; Xu, L.Y.; Meeks, C.; Lin, C.; Stone, R.; Rodgers, K.; Mitani, G. Pharmacogenetics of warfarin in a diverse patient population. J. Cardiovasc. Pharmacol. Ther., 2019, 24(6), 521-533.
[http://dx.doi.org/10.1177/1074248419843530] [PMID: 31064211]
[8]
Patel, J.A.; Gohil, K.J. Warfarin-herb interactions: A review and study based on assessment of clinical case reports in literature. Bol. Latinoam. Caribe Plantas Med. Aromat., 2008, 7, 85-99.
[9]
Alkherat, A. M.; Alkhalidi, D. K. Assessment of knowledge and counseling practice of warfarin among pharmacists in UAE: A cross-sectional study. Pharm. Pract, 2022, 20(4), 1-7.
[http://dx.doi.org/10.18549/PharmPract.2022.4.2741]
[10]
Lin, J.F.; Fan, L.L.; Li, B.W.; Zhao, R.R.; Jiang, L.G.; Zhang, B.C.; Lu, Y.S.; Shao, J.W. A study to evaluate herb-drug interaction underlying mechanisms: An investigation of ginsenosides attenuating the effect of warfarin on cardiovascular diseases. Eur. J. Pharm. Sci., 2020, 142(105100), 105100.
[http://dx.doi.org/10.1016/j.ejps.2019.105100] [PMID: 31669385]
[11]
Choi, S.; Oh, D.S.; Jerng, U.M. A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. PLoS One, 2017, 12(8), e0182794.
[http://dx.doi.org/10.1371/journal.pone.0182794] [PMID: 28797065]
[12]
Zeng, J.; Gensheimer, M.F.; Rubin, D.L.; Athey, S.; Shachter, R.D. Uncovering interpretable potential confounders in electronic medical records. Nat. Commun., 2022, 13(1), 1014.
[http://dx.doi.org/10.1038/s41467-022-28546-8] [PMID: 35197467]
[13]
Zhang, X.; Chen, M.; Zhu, L.; Zhou, Q. Therapeutic risk and benefits of concomitantly using herbal medicines and conventional medicines: From the perspectives of evidence based on randomized controlled trials and clinical risk management. Evid. Based Complement. Alternat. Med., 2017, 2017, 1-17.
[http://dx.doi.org/10.1155/2017/9296404] [PMID: 28491115]
[14]
Leung, H.; Hung, A.; Hui, A.C.F.; Chan, T.Y.K. Warfarin overdose due to the possible effects of Lycium barbarum L. Food Chem. Toxicol., 2008, 46(5), 1860-1862.
[http://dx.doi.org/10.1016/j.fct.2008.01.008] [PMID: 18281140]
[15]
Zhuang, W.; Liu, S.; Zhao, X.; Sun, N.; He, T.; Wang, Y.; Jia, B.; Lin, X.; Chu, Y.; Xi, S. Interaction between chinese medicine and warfarin: Clinical and research update. Front. Pharmacol., 2021, 12, 751107.
[http://dx.doi.org/10.3389/fphar.2021.751107] [PMID: 34616303]
[16]
Rivera, C.A.; Ferro, C.L.; Bursua, A.J.; Gerber, B.S. Probable interaction between Lycium barbarum (goji) and warfarin. Pharmacotherapy, 2012, 32(3), e50-e53.
[http://dx.doi.org/10.1002/j.1875-9114.2012.01018.x] [PMID: 22392461]
[17]
Xie, H.J.; Fu, H.Y.; Zhu, C.F.; Huang, Z.; Charles, D.S. Effects of danshen injection (salvia miltiorrhiza) on pharmacodynamics and pharmacokinetics of warfarin in rats. Herald Med, 2009, 28, 36-39.
[http://dx.doi.org/10.3870/yydb.2009.01.011]
[18]
Tan, Y.Z.; Wu, A.C.; Tan, B.Y.; Wu, Y.H.; Tang, L.F.; Li, J.H. Study on the interactions of berberine displace other drug from their plasma proteins binding sites. Chin. Pharmacol. Bull, 2002, 18, 576-578.
[19]
Colalto, C. Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment. Pharmacol. Res., 2010, 62(3), 207-227.
[http://dx.doi.org/10.1016/j.phrs.2010.04.001] [PMID: 20399862]
[20]
Zhang, Z.; Ge, B.; Zhou, L.; Lam, T.N.; Zuo, Z. Induction of liver cytochrome P450s by Danshen–Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin. J. Ethnopharmacol., 2014, 154(3), 672-686.
[http://dx.doi.org/10.1016/j.jep.2014.04.047] [PMID: 24832110]
[21]
Soyata, A.; Nur Hasanah, A.; Rusdiana, T. Interaction of warfarin with herbs based on pharmacokinetic and pharmacodynamic parameters. Indones. J. Pharm., 2020, 2(2), 69.
[http://dx.doi.org/10.24198/idjp.v2i2.27289]
[22]
Zhang, J.; Tian, L.; Huang, J.; Huang, S.; Chai, T.; Shen, J. Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis. Cardiovasc. Ther., 2017, 35(1), 26-32.
[http://dx.doi.org/10.1111/1755-5922.12230] [PMID: 27661060]
[23]
Uehara, S.; Uno, Y.; Inoue, T.; Kawano, M.; Shimizu, M.; Toda, A.; Utoh, M.; Sasaki, E.; Yamazaki, H. Individual differences in metabolic clearance of s-warfarin efficiently mediated by polymorphic marmoset cytochrome P450 2C19 in livers. Drug Metab. Dispos., 2016, 44(7), 911-915.
[http://dx.doi.org/10.1124/dmd.116.070383] [PMID: 27098744]
[24]
Qiao, X.; Ji, S.; Yu, S.; Lin, X.; Jin, H.; Duan, Y.; Zhang, L.; Guo, D.; Ye, M. Identification of key licorice constituents which interact with cytochrome P450: evaluation by LC/MS/MS cocktail assay and metabolic profiling. AAPS J., 2014, 16(1), 101-113.
[http://dx.doi.org/10.1208/s12248-013-9544-9] [PMID: 24254844]
[25]
Xiang, Y.Z.; Shang, H.C.; Zhang, B.L. Advances in studies on chinese materia medica with antiplatelet function. Advances in studies on chinese materia medica with antiplatelet function. Chin. Tradit. Herbal Drugs, 2008, 39, 290-294.
[http://dx.doi.org/10.3321/j.issn:0253-2670.2008.02.04910.1002/chin.200810266]
[26]
Brantley, S.J.; Oberlies, N.H.; Kroll, D.J.; Paine, M.F. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations. J. Pharmacol. Exp. Ther., 2010, 332(3), 1081-1087.
[http://dx.doi.org/10.1124/jpet.109.161927] [PMID: 19934397]
[27]
Rizzuti, B.; Bartucci, R.; Pey, A.L.; Guzzi, R. Warfarin increases thermal resistance of albumin through stabilization of the protein lobe that includes its binding site. Arch. Biochem. Biophys., 2019, 676(108123), 108123.
[http://dx.doi.org/10.1016/j.abb.2019.108123] [PMID: 31580875]
[28]
Poór, M.; Boda, G.; Needs, P.W.; Kroon, P.A.; Lemli, B.; Bencsik, T. Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme. Biomed. Pharmacother., 2017, 88, 574-581.
[http://dx.doi.org/10.1016/j.biopha.2017.01.092] [PMID: 28135601]
[29]
Jiang, X.; Williams, K.M.; Liauw, W.S.; Ammit, A.J.; Roufogalis, B.D.; Duke, C.C.; Day, R.O.; McLachlan, A.J. Effect of St John’s wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br. J. Clin. Pharmacol., 2004, 57(5), 592-599.
[http://dx.doi.org/10.1111/j.1365-2125.2003.02051.x] [PMID: 15089812]
[30]
Brandin, H.; Myrberg, O.; Rundlöf, T.; Arvidsson, A.K.; Brenning, G. Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy. Eur. J. Clin. Pharmacol., 2007, 63(6), 565-570.
[http://dx.doi.org/10.1007/s00228-007-0289-1] [PMID: 17468864]
[31]
Etheridge, A.; Black, S.; Patel, P.; So, J.; Mathews, J. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med., 2007, 73(8), 731-741.
[http://dx.doi.org/10.1055/s-2007-981550] [PMID: 17611934]
[32]
Mouly, S.; Lloret-Linares, C.; Sellier, P.O.; Sene, D.; Bergmann, J.F. Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John’s Wort? Pharmacol. Res., 2017, 118, 82-92.
[http://dx.doi.org/10.1016/j.phrs.2016.09.038] [PMID: 27693910]
[33]
Thomford, N.; Dzobo, K.; Chopera, D.; Wonkam, A.; Maroyi, A.; Blackhurst, D.; Dandara, C. In vitro reversible and time-dependent cyp450 inhibition profiles of medicinal herbal plant extracts newbouldia laevis and cassia abbreviata: Implications for herb-drug interactions. Molecules, 2016, 21(7), 891.
[http://dx.doi.org/10.3390/molecules21070891] [PMID: 27399660]
[34]
Cheng, C.; Qian, J.; Wang, Z.; Li, W.; Huang, C.; Chen, M.; Dong, Y.; Lian, L.; Sun, W. Influences of corydalis decumbens on the activities of CYP450 enzymes in rats with a cocktail approach. BioMed Res. Int., 2019, 2019, 1-9.
[http://dx.doi.org/10.1155/2019/9614781] [PMID: 30800683]
[35]
Cui, M.; Li, C.; Kong, X.; Zhang, K.; Liu, Y.; Hu, Q.; Ma, Y.; Li, Y.; Chen, T. Influence of Flavonoids from Galium verum L. on the activities of cytochrome P450 isozymes and pharmacokinetic and pharmacodynamic of warfarin in rats. Pharmacogn. Mag., 2019, 15(65), 645.
[http://dx.doi.org/10.4103/pm.pm_584_18]
[36]
Zhang, F.; Huang, J.; He, R.J.; Wang, L.; Huo, P.C.; Guan, X.Q.; Fang, S.Q.; Xiang, Y.W.; Jia, S.N.; Ge, G.B. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism. Phytomedicine, 2020, 77(153287), 153287.
[http://dx.doi.org/10.1016/j.phymed.2020.153287] [PMID: 32739573]
[37]
Jarukamjorn, K.; Sukkasem, N.; Chatuphonprasert, W. Altered cytochrome P450 profiles by Plumbago indica Linn. and plumbagin after oral administration in mice. Pharmacogn. Mag., 2018, 14(58), 507.
[http://dx.doi.org/10.4103/pm.pm_88_18]
[38]
Ge, B.; Zhang, Z.; Zuo, Z. Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: A pharmacokinetic and pharmacodynamics study. Chin. Med., 2016, 11(1), 7.
[http://dx.doi.org/10.1186/s13020-016-0078-9] [PMID: 26925159]
[39]
Chen, F.; Li, L.; Tian, D.D. Salvia miltiorrhiza roots against cardiovascular disease: Consideration of herb-drug interactions. BioMed Res. Int., 2017, 2017, 1-12.
[http://dx.doi.org/10.1155/2017/9868694] [PMID: 28473993]
[40]
Lash, D.B.; Ward, S. CYP2C9-mediated warfarin and milk thistle interaction. J. Clin. Pharm. Ther., 2020, 45(2), 368-369.
[http://dx.doi.org/10.1111/jcpt.13064] [PMID: 31633199]
[41]
Mohammed Abdul, M.I.; Jiang, X.; Williams, K.M.; Day, R.O.; Roufogalis, B.D.; Liauw, W.S.; Xu, H.; McLachlan, A.J. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br. J. Pharmacol., 2008, 154(8), 1691-1700.
[http://dx.doi.org/10.1038/bjp.2008.210] [PMID: 18516070]
[42]
Kasperkiewicz, K.; Ponczek, M.B.; Owczarek, J.; Guga, P.; Budzisz, E. Antagonists of vitamin k—popular coumarin drugs and new synthetic and natural coumarin derivatives. Molecules, 2020, 25(6), 1465.
[http://dx.doi.org/10.3390/molecules25061465] [PMID: 32213944]
[43]
Alnaqeeb, M.; Mansor, K.A.; Mallah, E.M.; Ghanim, B.Y.; Idkaidek, N.; Qinna, N.A. Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts. BMC Complement. Altern. Med., 2019, 19(1), 29.
[http://dx.doi.org/10.1186/s12906-019-2436-5] [PMID: 30678660]
[44]
Kusmardi, K.; Azzahra Baihaqi, L.; Estuningtyas, A.; Sahar, N.; Sunaryo, H.; Tedjo, A. Ethanol extract of pomegranate (Punica granatum) peel in increasing the expression of caspase-3 in DSS-induced mice. Int. J. Inflamm., 2021, 2021, 1-7.
[http://dx.doi.org/10.1155/2021/4919410] [PMID: 34900217]
[45]
Ariyaratna, R.; Amarasinghe, N.R.; Gunawardena, D.C. Antioxidant phenolic constituents from the fruits of careya arborea. In: Agricultural, Biological and Medical Sciences Editorial Board; Peradeniya University Research Sessions Purse., 2007; 12, .
[46]
Kang, M.J.; Cho, J.Y.; Shim, B.H.; Kim, D.K.; Lee, J. Bioavailability enhancing activities of natural compounds from medicinal plants. J. Med. Plants Res., 2009, 3, 1204-1211.
[47]
Di Bari, L.; Ripoli, S.; Pradhan, S.; Salvadori, P. Interactions between quercetin and Warfarin for albumin binding: A new eye on food/drug interference. Chirality, 2010, 22(6), 593-596.
[http://dx.doi.org/10.1002/chir.20794] [PMID: 19902529]
[48]
Kaneko, K.; Suzuki, K.; Iwadate-Iwata, E.; Kato, I.; Uchida, K.; Onoue, M. Evaluation of food-drug interaction of guava leaf tea. Phytother. Res., 2013, 27(2), 299-305.
[http://dx.doi.org/10.1002/ptr.4724] [PMID: 22566187]
[49]
Si, D.; Wang, Y.; Zhou, Y.H.; Guo, Y.; Wang, J.; Zhou, H.; Li, Z.S.; Fawcett, J.P. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab. Dispos., 2009, 37(3), 629-634.
[http://dx.doi.org/10.1124/dmd.108.023416] [PMID: 19074529]
[50]
Moon, J.Y.; Chang, B.C.; Lee, K.E.; Bang, J.S.; Gwak, H.S. Effects of pregnane X receptor genetic polymorphisms on stable warfarin doses. J. Cardiovasc. Pharmacol. Ther., 2015, 20(6), 532-538.
[http://dx.doi.org/10.1177/1074248415578906] [PMID: 25848132]
[51]
Shahabi, P.; Lamothe, F.; Dumas, S.; Rouleau-Mailloux, É.; Feroz Zada, Y.; Provost, S.; Asselin, G.; Mongrain, I.; Valois, D.; Gaulin Marion, M.J.; Lemieux Perreault, L.P.; Perreault, S.; Dubé, M.P. Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort. Pharmacogenomics J., 2019, 19(2), 147-156.
[http://dx.doi.org/10.1038/s41397-017-0005-1] [PMID: 29298995]
[52]
Flora, D.R.; Rettie, A.E.; Brundage, R.C.; Tracy, T.S. CYP2C9 genotype-dependent warfarin pharmacokinetics: Impact of CYP2C9 genotype on R- and S-warfarin and their oxidative metabolites. J. Clin. Pharmacol., 2017, 57(3), 382-393.
[http://dx.doi.org/10.1002/jcph.813] [PMID: 27539372]
[53]
Shaw, K.; Amstutz, U.; Kim, R.B.; Lesko, L.J.; Turgeon, J.; Michaud, V.; Hwang, S.; Ito, S.; Ross, C.; Carleton, B.C. Clinical practice recommendations on genetic testing of CYP2C9 and VKORC1 variants in warfarin therapy. Ther. Drug Monit., 2015, 37(4), 428-436.
[http://dx.doi.org/10.1097/FTD.0000000000000192] [PMID: 26186657]
[54]
Wang, M.; Zeraatkar, D.; Obeda, M.; Lee, M.; Garcia, C.; Nguyen, L.; Agarwal, A.; Al-Shalabi, F.; Benipal, H.; Ahmad, A.; Abbas, M.; Vidug, K.; Holbrook, A. Drug-drug interactions with warfarin: A systematic review and meta-analysis. Br. J. Clin. Pharmacol., 2021, 87(11), 4051-4100.
[http://dx.doi.org/10.1111/bcp.14833] [PMID: 33769581]
[55]
Vega, A.J.; Smith, C.; Matejowsky, H.G.; Thornhill, K.J.; Borne, G.E.; Mosieri, C.N.; Shekoohi, S.; Cornett, E.M.; Kaye, A.D. Warfarin and antibiotics: Drug interactions and clinical considerations. Life, 2023, 13(8), 1661.
[http://dx.doi.org/10.3390/life13081661] [PMID: 37629518]
[56]
Clark, N.P.; Hoang, K.; Delate, T.; Horn, J.R.; Witt, D.M. Warfarin interaction with hepatic cytochrome P-450 enzyme-inducing anticonvulsants. Clin. Appl. Thromb. Hemost., 2018, 24(1), 172-178.
[http://dx.doi.org/10.1177/1076029616687849] [PMID: 28118749]
[57]
Blickstein, D.; Shaklai, M.; Inbal, A. Warfarin antagonism by avocado. Lancet, 1991, 337(8746), 914-915.
[http://dx.doi.org/10.1016/0140-6736(91)90244-J] [PMID: 1672990]
[58]
Nutescu, E.A.; Shapiro, N.L.; Ibrahim, S.; West, P. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin. Drug Saf., 2006, 5(3), 433-451.
[http://dx.doi.org/10.1517/14740338.5.3.433] [PMID: 16610971]
[59]
Minighin, E.C.; Bragança, K.P.; Anastácio, L.R. Warfarin drug interaction with vitamin K and other foodstuffs. Rev. Chil. Nutr., 2020, 47(3), 470-477.
[http://dx.doi.org/10.4067/S0717-75182020000300470]
[60]
Robinson, D.S.; Benjamin, D.M.; McCormack, J.J. Interaction of warfarin and nonsystemic gastrointestinal drugs. Clin. Pharmacol. Ther., 1971, 12(3), 491-495.
[http://dx.doi.org/10.1002/cpt1971123491] [PMID: 5567801]
[61]
Smith, E.C.; Skalski, R.J.; Johnson, G.C.; Rossi, G.V. Interaction of ascorbic acid and warfarin. JAMA, 1972, 221(10), 1166.
[http://dx.doi.org/10.1001/jama.1972.03200230052025] [PMID: 4679014]
[62]
Aktas, C.; Şenkal, V.; Sarikaya, S.; Karti, S. Bilberry potentiates warfarin effect? Turk. Geriatri Derg., 2011, 14, 79-81.
[63]
Lambert, J.P.; Cormier, J. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy, 2001, 21(4), 509-512.
[http://dx.doi.org/10.1592/phco.21.5.509.34492] [PMID: 11310527]
[64]
Zhang, J.; Tian, L.; Xie, B. Bleeding due to a probable interaction between warfarin and Gouqizi ( Lycium Barbarum L.). Toxicol. Rep., 2015, 2, 1209-1212.
[http://dx.doi.org/10.1016/j.toxrep.2015.08.011] [PMID: 28962463]
[65]
Lam, A.Y.; Elmer, G.W.; Mohutsky, M.A. Possible interaction between warfarin and Lycium barbarum L. Ann. Pharmacother., 2001, 35(10), 1199-1201.
[http://dx.doi.org/10.1345/aph.1Z442] [PMID: 11675844]
[66]
Potterat, O. Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Med., 2010, 76(1), 7-19.
[http://dx.doi.org/10.1055/s-0029-1186218] [PMID: 19844860]
[67]
Ansell, J.; Hirsh, J.; Hylek, E.; Jacobson, A.; Crowther, M.; Palareti, G. Pharmacology and management of the vitamin K antagonists. American Coll. Ches. Phys. Evidence-Based Clin. Prac. Gui., 2008, 133(6), 160-198.
[http://dx.doi.org/10.1378/chest.08-0670]
[68]
Mellen, C.K.; Ford, M.; Rindone, J.P. Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. Br. J. Clin. Pharmacol., 2010, 70(1), 139-142.
[http://dx.doi.org/10.1111/j.1365-2125.2010.03674.x] [PMID: 20642557]
[69]
Li, Z.; Seeram, N.P.; Carpenter, C.L.; Thames, G.; Minutti, C.; Bowerman, S. Cranberry does not affect prothrombin time in male subjects on warfarin. J. Am. Diet. Assoc., 2006, 106(12), 2057-2061.
[http://dx.doi.org/10.1016/j.jada.2006.09.012] [PMID: 17126638]
[70]
Taylor, J.R.; Wilt, V.M. Probable antagonism of warfarin by green tea. Ann. Pharmacother., 1999, 33(4), 426-428.
[http://dx.doi.org/10.1345/aph.18238] [PMID: 10332534]
[71]
Temeesak, N.; Kheokasem, N.; Phatcharawongsagorn, N. The effects of herbs or dietary supplements on international normalized ratio in warfarin users: A retrospective study at phramongkutklao hospital. Thai. Pharmaceut. Health Sci. J., 2015, 10, 139-146.
[72]
Monterrey-Rodríguez, J.; Feliú, J.F.; Rivera-Miranda, G.C. Interaction between warfarin and mango fruit. Ann. Pharmacother., 2002, 36(5), 940-941.
[http://dx.doi.org/10.1177/106002800203600504] [PMID: 12014354]
[73]
Moeinipour, A.; Teshnizi, A.; Manafi, M.; Yavari, B.; Moeinipour, H.; Hoseinikhah, Y. Possible interaction of warfarin with peppermint herbal tea: A case report. Rev. Clin. Med., 2017, 4, 83-86.
[74]
Jarvis, S.; Li, C.; Bogle, R.G. Possible interaction between pomegranate juice and warfarin. Emerg. Med. J., 2010, 27(1), 74-75.
[http://dx.doi.org/10.1136/emj.2007.055855] [PMID: 20029019]
[75]
Komperda, K.E. Potential interaction between pomegranate juice and warfarin. Pharmacotherapy, 2009, 29(8), 1002-1006.
[http://dx.doi.org/10.1592/phco.29.8.1002] [PMID: 19637955]
[76]
Friedman, J.A.; Taylor, S.A.; McDermott, W.; Alikhani, P. Multifocal and recurrent subarachnoid hemorrhage due to an herbal supplement containing natural coumarins. Neurocrit. Care, 2007, 7(1), 76-80.
[http://dx.doi.org/10.1007/s12028-007-0075-z] [PMID: 17634840]
[77]
Cambria-Kiely, J.A. Effect of soy milk on warfarin efficacy. Ann. Pharmacother., 2002, 36(12), 1893-1896.
[http://dx.doi.org/10.1345/aph.1C160] [PMID: 12452752]
[78]
Kudo, T. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. Artery, 1990, 17(4), 189-201.
[PMID: 2360879]
[79]
Karlson, B.; Leijd, B.; Hellström, K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med. Scand., 1986, 220(4), 347-350.
[http://dx.doi.org/10.1111/j.0954-6820.1986.tb02776.x] [PMID: 3541503]
[80]
Chiffoleau, A.; Huguenin, H.; Allain-Veyrac, G. Does melilot interact with acenocoumarol? (Melilot-ruscus aculeatus). Therapie, 2001, 56(3), 321-322.
[PMID: 11475815]
[81]
Hogan, R.P., III Hemorrhagic diathesis caused by drinking an herbal tea. JAMA, 1983, 249(19), 2679-2680.
[http://dx.doi.org/10.1001/jama.1983.03330430055030] [PMID: 6133016]
[82]
Segal, R.; Pilote, L. Warfarin interaction with Matricaria chamomilla. CMAJ, 2006, 174(9), 1281-1282.
[http://dx.doi.org/10.1503/cmaj.051191] [PMID: 16636327]
[83]
Zeng, C.; Liu, Y.; Liu, G.F.; Li, X. Effects of ciwujia injection on four cytochrome p450 isoforms in rat liver microsomes in vitro. Chin. J. Clin. Pharmacol. Ther, 2012, 17, 164-170.
[84]
Lu, H.Y.; Cho, S.Y.; Park, S.U.; Jung, W.S.; Moon, S.K.; Park, J.M.; Ko, C.N. Do herbal formulas influence the international normalized ratio of patients taking warfarin? A retrospective study. Evid. Based Complement. Alternat. Med., 2015, 2015, 1-7.
[http://dx.doi.org/10.1155/2015/213927] [PMID: 25861354]
[85]
Gurley, B.J.; Gardner, S.F.; Hubbard, M.A.; Williams, D.K.; Gentry, W.B.; Cui, Y.; Ang, C.Y.W. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John’s wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging, 2005, 22(6), 525-539.
[http://dx.doi.org/10.2165/00002512-200522060-00006] [PMID: 15974642]
[86]
Premchand, R.K.; Samnani, N. Case report on interaction of warfarin with herbal medicine “kadha”. IHJ Cardiovascular Case Reports, 2021, 5(2), 116-118. [CVCR].
[http://dx.doi.org/10.1016/j.ihjccr.2021.06.001]
[87]
Gurwitz, J.H.; Field, T.S.; Radford, M.J.; Harrold, L.R.; Becker, R.; Reed, G.; DeBellis, K.; Moldoff, J.; Verzier, N. The safety of warfarin therapy in the nursing home setting. Am. J. Med., 2007, 120(6), 539-544.
[http://dx.doi.org/10.1016/j.amjmed.2006.07.045] [PMID: 17524757]
[88]
Lomonaco, T.; Ghimenti, S.; Piga, I.; Biagini, D.; Onor, M.; Fuoco, R.; Paolicchi, A.; Ruocco, L.; Pellegrini, G.; Trivella, M.G.; Di Francesco, F. Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study. Microchem. J., 2018, 136, 170-176.
[http://dx.doi.org/10.1016/j.microc.2017.02.010]
[89]
Patel, S.; Singh, R.; Preuss, C.V.; Patel, N. Warfarin; StatPearls Publishing: Treasure Island, 2023.
[90]
Kimmel, S.E.; Chen, Z.; Price, M.; Parker, C.S.; Metlay, J.P.; Christie, J.D.; Brensinger, C.M.; Newcomb, C.W.; Samaha, F.F.; Gross, R. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch. Intern. Med., 2007, 167(3), 229-235.
[http://dx.doi.org/10.1001/archinte.167.3.229] [PMID: 17296877]
[91]
Patel, J.A.; Gohil, K.J. Herb-drug interactions: A review and study based on assessment of clinical case reports in literature. Indian J. Pharmacol., 2007, 39(3), 129-139.
[http://dx.doi.org/10.4103/0253-7613.33432]
[92]
Kim, S.Y.; Kang, J.Y.; Hartman, J.; Park, S.H.; Jones, D.; Yun, C.H.; Boysen, G.; Miller, G. Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins. Drug Metab. Lett., 2013, 6(3), 157-164.
[http://dx.doi.org/10.2174/1872312811206030002] [PMID: 23331088]
[93]
Nagarakanti, R.; Wallentin, L.; Noack, H.; Brueckmann, M.; Reilly, P.; Clemens, A.; Connolly, S.J.; Yusuf, S.; Ezekowitz, M.D. Comparison of characteristics and outcomes of dabigatran versus warfarin in hypertensive patients with atrial fibrillation (from the RE-LY Trial). Am. J. Cardiol., 2015, 116(8), 1204-1209.
[http://dx.doi.org/10.1016/j.amjcard.2015.07.032] [PMID: 26282726]
[94]
Sun, Y.; Hu, D.; Stevens, S.; Lokhnygina, Y.; Becker, R.C.; Berkowitz, S.D.; Breithardt, G.; Hacke, W.; Halperin, J.L.; Hankey, G.J.; Mahaffey, K.W.; Nessel, C.C.; Piccini, J.P.; Singer, D.E.; Fox, K.A.A.; Patel, M.R. Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial. Thromb. Res., 2017, 156, 184-190.
[http://dx.doi.org/10.1016/j.thromres.2017.04.010] [PMID: 28433206]
[95]
Al-Khatib, S.M.; Mulder, H.; Wojdyla, D.; Lopes, R.D.; Wallentin, L.; Alexander, J.H.; Hijazi, Z.; Goto, S.; Granger, C.B. Apixaban versus warfarin in patients with atrial fibrillation and left ventricular hypertrophy. Circ. Arrhythm. Electrophysiol., 2021, 14(3), e009614.
[http://dx.doi.org/10.1161/CIRCEP.120.009614] [PMID: 33657831]
[96]
O’Donoghue, M.L.; Ruff, C.T.; Giugliano, R.P.; Murphy, S.A.; Grip, L.T.; Mercuri, M.F.; Rutman, H.; Shi, M.; Kania, G.; Cermak, O.; Braunwald, E.; Antman, E.M. Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation. Eur. Heart J., 2015, 36(23), 1470-1477.
[http://dx.doi.org/10.1093/eurheartj/ehv014] [PMID: 25687352]
[97]
Shah, S.V.; Gage, B.F. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. Circulation, 2011, 123(22), 2562-2570.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.110.985655] [PMID: 21606397]
[98]
Knudsen, J.F.; Sokol, G.H. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: Case report and review of the literature and MedWatch database. Pharmacotherapy, 2008, 28(4), 540-548.
[http://dx.doi.org/10.1592/phco.28.4.540] [PMID: 18363538]
[99]
Hunter, J.; Harnett, J.E. Interactions between complementary medicines and drugs used in primary care and oral COVID-19 antiviral drugs. Aust. J. Gen. Pract., 2023, 52(6), 345-357.
[http://dx.doi.org/10.31128/AJGP-12-22-6631] [PMID: 37291812]
[100]
Horn, J.R.; Hansten, P.D.; Chan, L.N. Proposal for a new tool to evaluate drug interaction cases. Ann. Pharmacother., 2007, 41(4), 674-680.
[http://dx.doi.org/10.1345/aph.1H423] [PMID: 17389673]
[101]
Ji, H.; Zhang, G.; Yue, F.; Zhou, X. Adverse event due to a likely interaction between sodium aescinate and ginkgo biloba extract: A case report. J. Clin. Pharm. Ther., 2017, 42(2), 237-238.
[http://dx.doi.org/10.1111/jcpt.12500] [PMID: 28144968]
[102]
Nayeri, A.; Wu, S.; Adams, E.; Tanner, C.; Meshman, J.; Saini, I.; Reid, W. Acute calcineurin inhibitor nephrotoxicity secondary to turmeric intake: A case report. Transplant. Proc., 2017, 49(1), 198-200.
[http://dx.doi.org/10.1016/j.transproceed.2016.11.029] [PMID: 28104136]
[103]
Damato, A.; Larocca, M.; Rondini, E.; Menga, M.; Pinto, C.; Versari, A. Severe rhabdomylosis during treatment with trabectedin in combination with herbal drug in patient with metastatic synovial sarcoma: A case report. Case Rep. Oncol., 2017, 10(1), 258-264.
[http://dx.doi.org/10.1159/000464440] [PMID: 28512407]
[104]
Khalid, Z.; Osuagwu, F.C.; Shah, B.; Roy, N.; Dillon, J.E.; Bradley, R. Celery root extract as an inducer of mania induction in a patient on venlafaxine and St John’s Wort. Postgrad. Med., 2016, 128(7), 682-683.
[http://dx.doi.org/10.1080/00325481.2016.1218263] [PMID: 27467225]
[105]
Kang, Y.C.; Chen, M.H.; Lai, S.L. Potentially unsafe herb–drug interactions between a commercial product of noni juice and phenytoin: A case report. Acta Neurol. Taiwan., 2015, 24(2), 43-46.
[PMID: 26179835]
[106]
Myers, A.P.; Watson, T.A.; Strock, S.B. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction. Pharmacotherapy, 2015, 35(3), e9-e12.
[http://dx.doi.org/10.1002/phar.1550] [PMID: 25756365]
[107]
Ferreira, P.G.; Costa, S.; Dias, N.; Ferreira, A.J.; Franco, F. Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine. J. Bras. Pneumol., 2014, 40(3), 313-318.
[http://dx.doi.org/10.1590/S1806-37132014000300015] [PMID: 25029655]
[108]
Melchardt, T.; Magnes, T.; Weiss, L.; Grundbichler, M.; Strasser, M.; Hufnagl, C.; Moik, M.; Greil, R.; Egle, A. Liver toxicity during temozolomide chemotherapy caused by Chinese herbs. BMC Complement. Altern. Med., 2014, 14(1), 115.
[http://dx.doi.org/10.1186/1472-6882-14-115] [PMID: 24679099]
[109]
Carbajal, R.; Yisfalem, A.; Pradhan, N.; Baumstein, D.; Chaudhari, A. Case report: Boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient. Transplant. Proc., 2014, 46(7), 2400-2402.
[http://dx.doi.org/10.1016/j.transproceed.2014.01.021] [PMID: 24981811]
[110]
Carter, J.; Yeh, R.F.; Braunschweig, I.; Barta, S.K. Unreported use of an herbal supplement resulting in decreased clearance of intravenous busulfan in a patient undergoing auto-SCT. Bone Marrow Transplant., 2014, 49(2), 313-314.
[http://dx.doi.org/10.1038/bmt.2013.169] [PMID: 24185586]
[111]
Açıkgöz, S.K.; Açıkgöz, E. Gastrointestinal bleeding secondary to interaction of Artemisia absinthium with warfarin. dmdi, 2013, 28(3), 187-189.
[http://dx.doi.org/10.1515/dmdi-2013-0021] [PMID: 23770559]
[112]
Strippoli, S.; Lorusso, V.; Albano, A.; Guida, M. Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin. BMC Complement. Altern. Med., 2013, 13(1), 199.
[http://dx.doi.org/10.1186/1472-6882-13-199] [PMID: 23899130]
[113]
Hou, Q.; Han, W.; Fu, X. Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome. Eur. J. Clin. Pharmacol., 2013, 69(10), 1861-1862.
[http://dx.doi.org/10.1007/s00228-013-1537-1] [PMID: 23765408]
[114]
Orr, A.; Parker, R. Red clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexate. Menopause Int., 2013, 19(3), 133-134.
[http://dx.doi.org/10.1177/1754045313502473] [PMID: 24072635]
[115]
Tamura, S.; Warabi, Y.; Matsubara, S. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement. J. Clin. Pharm. Ther., 2012, 37(6), 724-725.
[http://dx.doi.org/10.1111/j.1365-2710.2012.01350.x] [PMID: 22642738]
[116]
Van Strater, A.C.P.; Bogers, J.P.A.M. Interaction of St John’s wort (Hypericum perforatum) with clozapine. Int. Clin. Psychopharmacol., 2012, 27(2), 121-124.
[http://dx.doi.org/10.1097/YIC.0b013e32834e8afd] [PMID: 22113252]
[117]
Mateo-Carrasco, H.; Gálvez-Contreras, M.C.; Fernández-Ginés, F.D.; Nguyen, T.V. Elevated liver enzymes resulting from an interaction between Raltegravir and Panax ginseng : A case report and brief review. dmdi, 2012, 27(3), 171-175.
[http://dx.doi.org/10.1515/dmdi-2012-0019] [PMID: 23092794]
[118]
Naccarato, M.; Yoong, D.; Gough, K. A potential drug-herbal interaction between Ginkgo biloba and efavirenz. J. Int. Assoc. Physicians AIDS Care, 2012, 11(2), 98-100.
[http://dx.doi.org/10.1177/1545109711435364] [PMID: 22323244]
[119]
Bossaer, J.B.; Odle, B.L. Probable etoposide interaction with Echinacea. J. Diet. Suppl., 2012, 9(2), 90-95.
[http://dx.doi.org/10.3109/19390211.2012.682643] [PMID: 22607644]
[120]
Uygur Bayramıçlı, O.; Kalkay, M.N.; Oskay Bozkaya, E.; Doğan Köse, E.; Iyıgün, O.; Görük, M.; Sezgin, G. St. John’s wort (Hypericum perforatum) and warfarin: Dangerous liaisons! Turk. J. Gastroenterol., 2011, 22(1), 115.
[http://dx.doi.org/10.4318/tjg.2011.0175] [PMID: 21480130]
[121]
Hamann, G.L.; Campbell, J.D.; George, C.M. Warfarin-cranberry juice interaction. Ann. Pharmacother., 2011, 45(3), 420.
[http://dx.doi.org/10.1345/aph.1P451] [PMID: 21364039]
[122]
Su, Q.; Li, Y. Interaction between warfarin and the herbal product Shengmai-yin: A case report of intracerebral hematoma. Yonsei Med. J., 2010, 51(5), 793-796.
[http://dx.doi.org/10.3349/ymj.2010.51.5.793] [PMID: 20635460]
[123]
Hurren, K.M.; Lewis, C.L. Probable interaction between warfarin and bee pollen. Am. J. Health Syst. Pharm., 2010, 67(23), 2034-2037.
[http://dx.doi.org/10.2146/ajhp090489] [PMID: 21098375]
[124]
Sobieraj, D.M.; Freyer, C.W. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus. Ann. Pharmacother., 2010, 44(7-8), 1334-1337.
[http://dx.doi.org/10.1345/aph.1P148] [PMID: 20516361]
[125]
Bilgi, N.; Bell, K.; Ananthakrishnan, A.N.; Atallah, E. Imatinib and Panax ginseng: A potential interaction resulting in liver toxicity. Ann. Pharmacother., 2010, 44(5), 926-928.
[http://dx.doi.org/10.1345/aph.1M715] [PMID: 20332334]
[126]
Corrigan, M.A.; Atkinson, K.M.; Sha, B.E.; Crank, C.W. Evaluation of pharmacy-implemented medication reconciliation directed at antiretroviral therapy in hospitalized HIV/AIDS patients. Ann. Pharmacother., 2010, 44(1), 222-223.
[http://dx.doi.org/10.1345/aph.1M052] [PMID: 20040697]
[127]
Gordon, R.Y.; Becker, D.J.; Rader, D.J. Reduced efficacy of rosuvastatin by St. John’s Wort. Am. J. Med., 2009, 122(2), e1-e2.
[http://dx.doi.org/10.1016/j.amjmed.2008.09.033] [PMID: 19185075]
[128]
Prasad, K.P.R.C.; Tharangani, P.G.D.; Samaranayake, C.N. Recurrent relapses of depression in a patient established on sertraline after taking herbal medicinal mixtures: A herb–drug interaction? J. Psychopharmacol., 2009, 23(2), 216-219.
[http://dx.doi.org/10.1177/0269881108089808] [PMID: 18515463]
[129]
Carrasco, M.C.; Vallejo, J.R.; Pardo-de-Santayana, M.; Peral, D.; Martín, M.Á.; Altimiras, J. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother. Res., 2009, 23(12), 1795-1796.
[http://dx.doi.org/10.1002/ptr.2847] [PMID: 19441067]
[130]
Chang, Y.Y.; Liu, J.S.; Lai, S.L.; Wu, H.S.; Lan, M.Y. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern. Med., 2008, 47(5), 467-469.
[http://dx.doi.org/10.2169/internalmedicine.47.0620] [PMID: 18310985]
[131]
Beukel van den Bout-van den, C.J.P.; Bosch, M.E.W.; Burger, D.M.; Koopmans, P.P.; van der Ven, A.J.A.M. Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medications. AIDS, 2008, 22(10), 1243-1244.
[http://dx.doi.org/10.1097/QAD.0b013e32830261f4]
[132]
Hwang, S.W.; Han, H.S.; Lim, K.Y.; Han, J.Y. Drug interaction between complementary herbal medicines and gefitinib. J. Thorac. Oncol., 2008, 3(8), 942-943.
[http://dx.doi.org/10.1097/JTO.0b013e3181803f1e] [PMID: 18670318]
[133]
Werba, J.P.; Giroli, M.; Cavalca, V.; Nava, M.C.; Tremoli, E.; Dal Bo, L. The effect of green tea on simvastatin tolerability. Ann. Intern. Med., 2008, 149(4), 286-287.
[http://dx.doi.org/10.7326/0003-4819-149-4-200808190-00019] [PMID: 18711168]
[134]
Iida, R.; Otsuka, Y.; Matsumoto, K.; Kuriyama, S.; Hosoya, T. Pseudoaldosteronism due to the concurrent use of two herbal medicines containing glycyrrhizin: interaction of glycyrrhizin with angiotensin-converting enzyme inhibitor. Clin. Exp. Nephrol., 2006, 10(2), 131-135.
[http://dx.doi.org/10.1007/s10157-006-0415-x] [PMID: 16791400]
[135]
Epstein, R.J.; Leung, T.W.T.; Cheung, P.S.Y. Panmucositis and chemosensitisation associated with betel quid chewing during dose-dense adjuvant breast cancer chemotherapy. Cancer Chemother. Pharmacol., 2006, 58(6), 835-837.
[http://dx.doi.org/10.1007/s00280-006-0218-5] [PMID: 16532344]
[136]
Al Faraj, S. Antagonism of the anticoagulant effect of warfarin caused by the use of Commiphora molmol as a herbal medication: A case report. Ann. Trop. Med. Parasitol., 2017, 4983, 10-12.
[http://dx.doi.org/10.1179/136485905X17434] [PMID: 15814041]
[137]
AlMatar, M.; Makky, E.A.; Mahmood, M.H.; Wen, K.X.; Qi, T.B.G. In vitro antioxidant and antimicrobial studies of ethanolic plant extracts of p. granatum, o. stamineus, a. bilimbi, m. nigra, and e. longifolia. Curr. Pharm. Biotechnol., 2022, 23(10), 1284-1312.
[http://dx.doi.org/10.2174/1389201022666210615113854] [PMID: 34132178]
[138]
Makky, E.A.; AlMatar, M.; Mahmood, M.H.; Ting, O.W.; Qi, W.Z. Evaluation of the antioxidant and antimicrobial activities of ethyl acetate extract of saccharomyces cerevisiae. Food Technol. Biotechnol., 2021, 59(2), 127-136.
[http://dx.doi.org/10.17113/ftb.59.02.21.6658] [PMID: 34316274]
[139]
Tadros, R.; Shakib, S. Warfarin--indications, risks and drug interactions. Aust. Fam. Physician, 2010, 39(7), 476-479.
[PMID: 20628660]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy